These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28097894)

  • 1. High serum YKL-40 level positively correlates with coronary artery disease.
    Jin Y; Cao JN; Wang CX; Feng QT; Ye XH; Xu X; Yang CJ
    Biomark Med; 2017 Feb; 11(2):133-139. PubMed ID: 28097894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease.
    Akboga MK; Yalcin R; Sahinarslan A; Yilmaz Demirtas C; Abaci A
    Int J Cardiol; 2016 Dec; 224():323-327. PubMed ID: 27668705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.
    Mathiasen AB; Harutyunyan MJ; Jørgensen E; Helqvist S; Ripa R; Gøtze JP; Johansen JS; Kastrup J
    Scand J Clin Lab Invest; 2011 Sep; 71(5):439-47. PubMed ID: 21827355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
    Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
    Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease.
    Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
    Atherosclerosis; 2010 Jun; 210(2):590-5. PubMed ID: 20056225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of serum β2-microglobulin predict severity of coronary artery disease.
    You L; Xie R; Hu H; Gu G; Zheng H; Zhang J; Yang X; He X; Cui W
    BMC Cardiovasc Disord; 2017 Mar; 17(1):71. PubMed ID: 28249620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum YKL-40 Level Positively Correlates With Uterine Leiomyomas.
    Guo W; Wang J; Wei H
    Reprod Sci; 2016 Nov; 23(11):1559-1564. PubMed ID: 27170664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum YKL-40 levels with the presence and severity of coronary artery disease in patients with obstructive sleep apnea syndrome.
    Sui X; Gao C
    Clin Invest Med; 2013 Dec; 36(6):E306-11. PubMed ID: 24309227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients.
    Çetin M; Erdoğan T; Kırış T; Özer S; Çinier G; Emlek N; Durak H; Şatıroğlu Ö
    Clin Exp Hypertens; 2020; 42(3):271-274. PubMed ID: 31204510
    [No Abstract]   [Full Text] [Related]  

  • 13. "Correlation of red blood cell distribution width with the severity of coronary artery disease-A single center study".
    Nagula P; Karumuri S; Otikunta AN; Yerrabandi SRV
    Indian Heart J; 2017; 69(6):757-761. PubMed ID: 29174254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis.
    Gao W; Li J; Ni H; Shi H; Qi Z; Zhu S; Hao C; Xie Q; Luo X; Xie K
    J Atheroscler Thromb; 2019 Jan; 26(1):31-38. PubMed ID: 29769455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Plasma Adiponectin and Waist-hip Ratio with Coronary Artery Disease.
    Rashiti P; Elezi S; Behluli I; Mucaj S
    Med Arch; 2016 Dec; 70(6):413-418. PubMed ID: 28210011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis.
    Fuksiewicz M; Kotowicz B; Rutkowski A; Achinger-Kawecka J; Wagrodzki M; Kowalska MM
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818765209. PubMed ID: 29642772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population.
    Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
    Cytokine; 2011 Apr; 54(1):51-5. PubMed ID: 21257319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the serum alkaline phosphatase level and the severity of coronary artery disease.
    Sahin I; Karabulut A; Gungor B; Avci II; Okuyan E; Kizkapan F; Yildiz SS; Can MM; Dinckal M
    Coron Artery Dis; 2014 Jun; 25(4):349-52. PubMed ID: 24769515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
    Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
    Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease.
    Sinning C; Zengin E; Waldeyer C; Seiffert M; Schnabel RB; Lubos E; Zeller T; Bickel C; Blankenberg S; Clemmensen PM; Westermann D
    Clin Res Cardiol; 2016 Nov; 105(11):901-911. PubMed ID: 27364941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.